Fondaparinux: all 46 studies that test it

Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• Thromboprophylaxis in Lower Limb ImmobilisationRecruitingNCT06370273Phase 3
• Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in CancerCompletedNCT02744092Not applicableResults posted
• Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity ArthroplastyCompletedNCT01809054Phase 4Results posted
• Fondaparinux in Critically Ill Patients With Renal FailureCompletedNCT01467583Phase 4Results posted
• The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese PatientsCompletedNCT00981409Phase 3Results posted
• Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart RhythmCompletedNCT00911300Phase 2Results posted
• The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese PatientsCompletedNCT00911157Phase 3Results posted
• The Effects of Arixtra on Wound Drainage Following Total Joint ArthroplastyCompletedNCT00909064Phase 4Results posted
• A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing SurgeryCompletedNCT00843492Phase 3Results posted
• A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical ProphylaxisTerminatedNCT00789399Not applicableResults posted
• Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)TerminatedNCT00673439Phase 2Results posted
• Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux.CompletedNCT00555438Phase 4Results posted
• Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic MalignancyTerminatedNCT00539942Phase 3Results posted
• The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma PatientsCompletedNCT00531843Phase 2/3Results posted
• Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill PatientsTerminatedNCT00521885Not applicableResults posted
• Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous ThromboembolismTerminatedNCT00423683Phase 3Results posted
• Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With ThrombosisCompletedNCT00412464Phase 1Results posted
• Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic CancerCompletedNCT00381888Phase 2Results posted
• Hip Fracture Study of GSK576428 (Fondaparinux Sodium)CompletedNCT00320424Phase 3Results posted
• Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)CompletedNCT00320398Phase 3Results posted
• Endovenous Laser Ablation in Acute Thrombophlebitis of the Varicose Great Saphenous VeinCompletedNCT05001776Phase 4
• Safety of Fondaparinux as Post Partum ThromboprophylaxisCompletedNCT04447378Phase 4
• Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19CompletedNCT04368377Phase 2
• Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With ThrombocytopeniaTerminatedNCT01727401Phase 4
• The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic SurgeryCompletedNCT01267305Not applicable
• "Pharmacokinetic Study of Fondaparinux in Inpatients With Renal Dysfunction"CompletedNCT01121770Phase 1
• Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal InsufficiencyTerminatedNCT00927602Phase 4
• Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical PatientsCompletedNCT00894283Early Phase 1
• Prophylaxis of Thromboembolic Complications Trial: Thromboprophylaxis Needed in Below Knee Plaster Cast Immobilization for Ankle and Foot FracturesStatus unknownNCT00881088Phase 2/3
• Prophylaxis Against DVTs After Primary Hip and Knee Replacement SurgeryStatus unknownNCT00767559Not applicable
• Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of ProgressionWithdrawnNCT00659399Phase 1
• Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia (HIT)WithdrawnNCT00603824Phase 4
• Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU PatientsTerminatedNCT00493896Phase 3
• Pharmacokinetic Study of Fondaparinux in Outpatients With Renal DysfunctionWithdrawnNCT00483600Not applicable
• Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung CancerCompletedNCT00476216Phase 1
• Fondaparinux to Prevent Thrombotic Complications and Graft Failure in Patients Undergoing Coronary Artery Bypass Graft Surgery: The Fonda CABG StudyStatus unknownNCT00474591Phase 3
• Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese VolunteersCompletedNCT00436787Phase 2
• Fondaparinux as Monotherapy for DVT and/or Pulmonary EmbolismCompletedNCT00413504Not applicable
• Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional TherapyWithdrawnNCT00377091Phase 4
• Study to Determine Effective Dosing of Fondaparinux in Obese PersonsWithdrawnNCT00346879Phase 1
• Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese PatientsCompletedNCT00333021Phase 3
• ARIXTRA Local Study For Registration In China.CompletedNCT00328939Phase 3
• Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure.TerminatedNCT00256100Not applicable
• Michelangelo - Oasis 5CompletedNCT00139815Phase 3
• A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)WithdrawnNCT00060554Phase 2
• A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO).CompletedNCT00038961Phase 3

← Fondaparinux overview